Analyst Ratings for Chemed (CHE)
CHE Rating Summary
CHE Price Target Summary
- Highest: $590.00 (Oppenheimer)
- Lowest: $520.00 (Jefferies)
- Average: $552.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$552.00 (+4.9%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 11%
Avg. $ Target:
$552.00 (+4.9%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 11%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | RBC Capital » Updated 7/30/2026 |
Ben Hendrix | Downgrade | Sector Perform (Outperform) |
548.00 (436.00) |
466.60 (526.32) |
12.8% | Details |
| 2/26/2026 | BofA Securities » Updated 7/29/2026 |
Joanna Gajuk | Downgrade | Neutral (Buy) |
550.00 (510.00) |
466.60 (526.32) |
12.8% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
